Nomograms for predicting recurrence of HER2 ‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
Cancer Medicine · 2024
DOI: 10.1002/cam4.70146 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Xudong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Nomograms, Breast Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Outstanding Youth Program of Heilongjiang Natural Science Foundation.
Abstract (Originalsprache)
Purpose
This study aimed to identify ultrasound and clinicopathological characteristics related to recurrence in HER2‐positive (HER2+) breast cancer, and to develop nomograms for predicting recurrence.
Methods
In this dual‐center study, we retrospectively enrolled 570 patients with HER2+ breast cancer. The ultrasound and clinicopathological characteristics of hormone receptor (HR)−/HER2+ patients and HR+/HER2+ patients were analyzed separately according to HR status. Eighty percent of the original samples from HR−/HER2+ and HR+/HER2+ patients were extracted by bootstrap sampling as the training cohorts, while the remaining 20% were used as the external validation cohorts. Informative characteristics were screened through univariate and multivariable Cox regression in the training cohorts and used to develop nomograms for predicting recurrence. The predictive accuracy was calculated using Harrell's C‐index and calibration curves.
Results
Three informative characteristics (axillary nodal status, calcification, and Adler degree) were identified in HR−/HER2+ patients, and another three (histological grade, axillary nodal status, and echogenic halo) in HR+/HER2+ patients. Based on these, two separate nomograms were constructed to assess recurrence risk. In the training cohorts, the C‐index was 0.740 (95% CI: 0.667–0.811) for HR−/HER2+ nomogram, and 0.749 (95% CI: 0.679–0.820) for HR+/HER2+ nomogram. In the validation cohorts, the C‐index was 0.708 (95% CI: 0.540–0.877) for HR−/HER2+ group, and 0.705 (95% CI: 0.557–0.853) for HR+/HER2+ group. The calibration curves also indicated the excellent accuracy of the nomograms.
Conclusions
Ultrasound performance of HER2+ breast cancers with different HR status was significantly different. Nomograms integrating ultrasound and clinicopathological characteristics exhibited favorable performance and have the potential to serve as a reliable method for predicting recurrence in heterogeneous breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Abdominal Ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Ultrasound Medicine, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Ultrasound molecular imaging Joint laboratory of Heilongjiang province (International Cooperation), Harbin, Heilongjiang, China.
ORCID-Profile: Jiawei Tian, Hao Cui, Lei Zhang
Förderung
- National Natural Science Foundation of China
- Outstanding Youth Program of Heilongjiang Natural Science Foundation
Zitieren
APA
Zhang, X., Kong, H., Liu, X., Li, Q., Fang, X., Wang, J., Qin, Z., Hu, N., Tian, J., Cui, H., & Zhang, L. (2024). Nomograms for predicting recurrence of HER2 ‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics. Cancer Medicine. https://doi.org/10.1002/cam4.70146
Vancouver
Zhang X, Kong H, Liu X, Li Q, Fang X, Wang J, et al. Nomograms for predicting recurrence of HER2 ‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics. Cancer Medicine. 2024. doi:10.1002/cam4.70146
BibTeX
@article{Zhang2024,
author = {Zhang, Xudong and Kong, Hanqing and Liu, Xiaoxue and Li, Qingxiang and Fang, Xinran and Wang, Junjia and Qin, Zihao and Hu, Nana and Tian, Jiawei and Cui, Hao and Zhang, Lei},
title = {Nomograms for predicting recurrence of HER2 ‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70146}
}
EUVIMED